Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.08 - $21.0 $4,020 - $1.06 Million
-50,261 Reduced 80.98%
11,805 $0
Q1 2022

May 16, 2022

SELL
$0.42 - $0.62 $630 - $930
-1,500 Reduced 2.36%
62,066 $29,000
Q4 2021

Feb 09, 2022

SELL
$0.56 - $1.71 $3,024 - $9,234
-5,400 Reduced 7.83%
63,566 $36,000
Q4 2020

May 19, 2021

SELL
$0.75 - $2.76 $25,950 - $95,495
-34,600 Reduced 33.41%
68,966 $114,000
Q3 2020

Sep 07, 2021

BUY
$0.61 - $1.17 $35,014 - $67,158
57,400 Added 124.33%
103,566 $97,000
Q2 2020

Sep 07, 2021

SELL
$0.47 - $0.72 $6,110 - $9,360
-13,000 Reduced 21.97%
46,166 $28,000
Q1 2020

Sep 07, 2021

BUY
$0.36 - $0.74 $5,400 - $11,100
15,000 Added 33.96%
59,166 $25,000
Q3 2019

Sep 07, 2021

BUY
$0.38 - $0.52 $13,073 - $17,890
34,405 Added 352.47%
44,166 $21,000
Q2 2019

Sep 07, 2021

SELL
$0.39 - $0.7 $1,966 - $3,530
-5,043 Reduced 34.07%
9,761 $3,000
Q4 2018

Sep 07, 2021

BUY
$0.39 - $0.7 $764 - $1,372
1,961 Added 15.27%
14,804 $5,000
Q3 2018

Sep 07, 2021

BUY
$0.44 - $3.02 $376 - $2,585
856 Added 7.14%
12,843 $6,000
Q4 2017

Sep 07, 2021

BUY
$0.68 - $4.19 $1,405 - $8,660
2,067 Added 20.84%
11,987 $48,000
Q4 2016

Sep 07, 2021

BUY
N/A
1,500 Added 17.81%
9,920 $8,000
Q3 2016

Sep 07, 2021

SELL
N/A
-10,000 Reduced 54.29%
8,420 $6,000
Q2 2016

Sep 07, 2021

BUY
N/A
2,976 Added 19.27%
18,420 $23,000
Q1 2016

Sep 07, 2021

BUY
N/A
15,444
15,444 $40,000

Others Institutions Holding AMPE

# of Institutions
1
Shares Held
96.6K
Call Options Held
0
Put Options Held
0

About Ampio Pharmaceuticals, Inc.


  • Ticker AMPE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 226,287,008
  • Market Cap $2.26M
  • Description
  • Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...
More about AMPE
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.